ALN-APP Clinical Trials

1 actively recruiting trial across 1 location

Also known as: mivelsiran

Pipeline

Phase 1: 1

Top Sponsors

Alnylam Pharmaceuticals1

Indications

Alzheimer's Disease1
Early-Onset Alzheimer Disease1

La Jolla, California1 trial

A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD

Clinical Trial Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.